Joao MD Siffert - Dec 19, 2022 Form 4 Insider Report for Design Therapeutics, Inc. (DSGN)

Signature
/s/ Mustapha Parekh, Attorney-in-Fact
Stock symbol
DSGN
Transactions as of
Dec 19, 2022
Transactions value $
$62,503
Form type
4
Date filed
12/21/2022, 04:00 PM
Previous filing
Feb 2, 2022
Next filing
Feb 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DSGN Common Stock Purchase $9.74K +1.15K +0.92% $8.47 126K Dec 19, 2022 Direct F1
transaction DSGN Common Stock Purchase $52.8K +6.3K +4.99% $8.38 133K Dec 20, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,250 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan ("ESPP") on November 15, 2021 and 1,220 shares acquired under the ESPP on May 13, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.32 to $8.44, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth herein.